All In Biotech

Drug Trial Radar · NCT00380627

Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

Quality of Life With Arcoxia in Women With Dysmenorrhea

Last checked: Nov 20, 2026Latest source record: Aug 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

337

Actual

Start

Sep 1, 2005

Primary completion

Jan 31, 2006

Study completion Jan 31, 2006

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
Sep 26, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Allow gynecologists to gain experience with arcoxia for treatment of dysmenorrhea.

Conditions

  • Pain

Interventions

  • MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 DaysDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Perception of menstrual pain, through the analog verbal scale during three days.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.